Data: Duke Global Health Innovation Center; Chart: Michelle McGhee/AxiosThe Biden administration’s purchase of 200 million additional Pfizer and Modern doses means the U.S. could fully vaccinate 300 million people with just those two vaccines — and 355 million more people if four additional vaccines gain FDA approval.Why it matters: The U.S. is home to 250 million adults, many of whom won’t elect to be vaccinated. It's also now in control of a big chunk of the global vaccine supply. The White House says the U.S. will eventually donate excess doses to other countries, but it hasn’t released a plan to do so. Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeThe state of play: The administration has been focused almost entirely on ensuring that every American who wants a vaccine will be able to get one by this summer. With the additional Pfizer and Moderna doses — and up to 40 million Johnson &
Delayed vaccine rollouts in poorer countries mean slower economic recovery in those countries and globally, and higher death tolls among unvaccinated vulnerable populations.